http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101940787-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101940787-B1 |
| titleOfInvention | A composition for treating skin wound comprising a stem cell culture medium treated with ginsenoside Rb3 as an active ingredient |
| abstract | The present invention relates to a culture medium for stem cell culture comprising ginsenoside Rb3 (ginsenoside Rb3) as an active ingredient, and a composition for treating wounds comprising a culture solution obtained by culturing stem cells in the composition, , It can increase the production of IL-6, VEGF, and adiponectin by stem cells and promotes cell proliferation and migration and is effective in treating wounds and the like. In addition, since the composition has no cytotoxicity and skin side effects, it can be safely used as a skin external preparation for cosmetics and medicines. |
| priorityDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.